BNP Paribas Financial Markets Takes $304,000 Position in Structure Therapeutics Inc. (NASDAQ:GPCR)
BNP Paribas Financial Markets purchased a new stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 11,218 shares of the company’s stock, valued at approximately $304,000. Other hedge funds and other institutional investors also recently […]
BNP Paribas Financial Markets purchased a new stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 11,218 shares of the company’s stock, valued at approximately $304,000. Other hedge funds and other institutional investors also recently […]
